Trial Profile
A retrospective study of rivaroxaban and dabigatran in nonvalvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 06 Oct 2016 New trial record